Study to Analyze the Efficacy of Acute Intake With a β-alanine Supplement in Recreational Cyclists (B-AC1)

Universidad Católica San Antonio de Murcia

Status: Completed

Conditions: Beta Alanine Supplementation

Treatments: Dietary Supplement: Beta Alanine low dose; Dietary Supplement: Beta Alanine high dose; Dietary Supplement: Control group

Study type: Interventional

Funder types: Other

Identifiers

NCT06180512

UCAMCFE-00029

Details and patient eligibility

About

Randomized, controlled, double-blind, single-center, double-blind clinical trial with three parallel arms depending on the product consumed (experimental product dose 1 and dose 2 and placebo product) to measure the efficacy of a sustained release beta alanine on physiological physical performance efficacy in recreational cyclists.

Full description

Subjects meeting the selection criteria will be randomly assigned to each of the study groups (investigational product dose 1 or dose 2, or placebo, depending on the group to which they have been assigned).

The product to be consumed is beta alanine. Participants will consume the product for 1 day. They will have to take four intakes every hour and a quarter, on the same day.

The study subjects will have to make 2 visits to the laboratory. In the first one, they will have to perform a 10-minute time trial, without consumption. In the second visit, they will perform the same performance test but with acute consumption of the product. Their physical and physiological performance will be evaluated.

The two tests will be separated by 7 days.

Enrollment: 75 patients

Sex: Male

Ages: 18 to 60 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Male cyclists with more than two years of cycling experience.
• Perform tests without fatigue.
• Road bike training at least twice a week.

Exclusion criteria

• Participants with chronic illness.
• Have a long-term injury that prevents you from training in the previous month.
• Inability to understand informed consent.
• Have consumed beta alanine in the three years prior to the start of the study.
• Consumption of other supplements that may alter performance.

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

75 participants in 3 patient groups, including a placebo group

Beta Alanine high dose

Experimental group

Description:

Consumption for 1 day.

Treatment:

Dietary Supplement: Beta Alanine high dose

Beta Alanine low dose

Experimental group

Description:

Consumption for 1 day.

Treatment:

Dietary Supplement: Beta Alanine low dose

Control group

Placebo Comparator group

Description:

Consumption for 1 day.

Treatment:

Dietary Supplement: Control group